How Accenture is using Google Cloud and Wiz to close security blind spots in modern multi-cloud infrastructure
United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read Pharma Industry News Eusa Pharma completes $115m acquisition of Sylvant for iMCD treatment Eusa Pharma has successfully acquired the global rights to Sylvant (siltuximab), a drug used in the treatment of… bypharmanewsdailyJanuary 20, 2019